# VEAPS: Vitamin E Atherosclerosis Prevention Study

> **NCT00114387** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Institute on Aging (NIA)** · enrollment: 353 (—)

## Conditions studied

- Atherosclerosis

## Interventions

- **DRUG:** DL-alpha-tocopherol

## Key facts

- **NCT ID:** NCT00114387
- **Lead sponsor:** National Institute on Aging (NIA)
- **Sponsor class:** NIH
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-07
- **Primary completion:** 2000-09
- **Final completion:** 2000-09
- **Target enrollment:** 353 (—)
- **Last updated:** 2009-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114387, "VEAPS: Vitamin E Atherosclerosis Prevention Study". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00114387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*